Literature DB >> 21813645

Potentiation of Helicobacter pylori CagA protein virulence through homodimerization.

Lisa Nagase1, Naoko Murata-Kamiya, Masanori Hatakeyama.   

Abstract

Chronic infection with Helicobacter pylori cagA-positive strains is associated with atrophic gastritis, peptic ulceration, and gastric carcinoma. The cagA gene product, CagA, is delivered into gastric epithelial cells via type IV secretion, where it undergoes tyrosine phosphorylation at the EPIYA motifs. Tyrosine-phosphorylated CagA binds and aberrantly activates the oncogenic tyrosine phosphatase SHP2, which mediates induction of elongated cell morphology (hummingbird phenotype) that reflects CagA virulence. CagA also binds and inhibits the polarity-regulating kinase partitioning-defective 1 (PAR1)/microtubule affinity-regulating kinase (MARK) via the CagA multimerization (CM) sequence independently of tyrosine phosphorylation. Because PAR1 exists as a homodimer, two CagA proteins appear to be passively dimerized through complex formation with a PAR1 dimer in cells. Interestingly, a CagA mutant that lacks the CM sequence displays a reduced SHP2 binding activity and exhibits an attenuated ability to induce the hummingbird phenotype, indicating that the CagA-PAR1 interaction also influences the morphological transformation. Here we investigated the role of CagA dimerization in induction of the hummingbird phenotype with the use of a chemical dimerizer, coumermycin. We found that CagA dimerization markedly stabilizes the CagA-SHP2 complex and thereby potentiates SHP2 deregulation, causing an increase in the number of hummingbird cells. Protrusions of hummingbird cells induced by chemical dimerization of CagA are further elongated by simultaneous inhibition of PAR1. This study revealed a role of the CM sequence in amplifying the magnitude of SHP2 deregulation by CagA, which, in conjunction with the CM sequence-mediated inhibition of PAR1, evokes morphological transformation that reflects in vivo CagA virulence.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21813645      PMCID: PMC3190882          DOI: 10.1074/jbc.M111.258673

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Structural basis and functional consequence of Helicobacter pylori CagA multimerization in cells.

Authors:  Shumei Ren; Hideaki Higashi; Huaisheng Lu; Takeshi Azuma; Masanori Hatakeyama
Journal:  J Biol Chem       Date:  2006-09-05       Impact factor: 5.157

Review 2.  The role of Shp2 (PTPN11) in cancer.

Authors:  M Golam Mohi; Benjamin G Neel
Journal:  Curr Opin Genet Dev       Date:  2007-01-16       Impact factor: 5.578

Review 3.  Tyrosine-phosphorylated bacterial effector proteins: the enemies within.

Authors:  Steffen Backert; Matthias Selbach
Journal:  Trends Microbiol       Date:  2005-10       Impact factor: 17.079

4.  Focal adhesion kinase is a substrate and downstream effector of SHP-2 complexed with Helicobacter pylori CagA.

Authors:  Ryouhei Tsutsumi; Atsushi Takahashi; Takeshi Azuma; Hideaki Higashi; Masanori Hatakeyama
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

5.  Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA.

Authors:  Masanori Naito; Takeshi Yamazaki; Ryouhei Tsutsumi; Hideaki Higashi; Kazunori Onoe; Shiho Yamazaki; Takeshi Azuma; Masanori Hatakeyama
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

6.  Conditional activation of Janus kinase (JAK) confers factor independence upon interleukin-3-dependent cells. Essential role of Ras in JAK-triggered mitogenesis.

Authors:  R Mizuguchi; M Hatakeyama
Journal:  J Biol Chem       Date:  1998-11-27       Impact factor: 5.157

7.  Activation and functional analysis of Janus kinase 2 in BA/F3 cells using the coumermycin/gyrase B system.

Authors:  M G Mohi; K i Arai; S Watanabe
Journal:  Mol Biol Cell       Date:  1998-12       Impact factor: 4.138

8.  Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse.

Authors:  Naomi Ohnishi; Hitomi Yuasa; Shinya Tanaka; Hirofumi Sawa; Motohiro Miura; Atsushi Matsui; Hideaki Higashi; Manabu Musashi; Kazuya Iwabuchi; Misao Suzuki; Gen Yamada; Takeshi Azuma; Masanori Hatakeyama
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-11       Impact factor: 11.205

9.  Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity.

Authors:  Iraj Saadat; Hideaki Higashi; Chikashi Obuse; Mayumi Umeda; Naoko Murata-Kamiya; Yasuhiro Saito; Huaisheng Lu; Naomi Ohnishi; Takeshi Azuma; Atsushi Suzuki; Shigeo Ohno; Masanori Hatakeyama
Journal:  Nature       Date:  2007-05-17       Impact factor: 49.962

Review 10.  Germ-line and somatic PTPN11 mutations in human disease.

Authors:  Marco Tartaglia; Bruce D Gelb
Journal:  Eur J Med Genet       Date:  2005-04-02       Impact factor: 2.708

View more
  17 in total

1.  c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains.

Authors:  Doreen Mueller; Nicole Tegtmeyer; Sabine Brandt; Yoshio Yamaoka; Eimear De Poire; Dionyssios Sgouras; Silja Wessler; Javier Torres; Adam Smolka; Steffen Backert
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

2.  Inhibition of polarity-regulating kinase PAR1b contributes to Helicobacter pylori inflicted DNA Double Strand Breaks in gastric cells.

Authors:  Andrea Zamperone; David Cohen; Markus Stein; Charlotte Viard; Anne Müsch
Journal:  Cell Cycle       Date:  2019-01-13       Impact factor: 4.534

Review 3.  Chronic inflammation and long-lasting changes in the gastric mucosa after Helicobacter pylori infection involved in gastric cancer.

Authors:  Hang Yang; Bin Wei; Bing Hu
Journal:  Inflamm Res       Date:  2021-09-21       Impact factor: 4.575

4.  Kinase Activity of PAR1b, Which Mediates Nuclear Translocation of the BRCA1 Tumor Suppressor, Is Potentiated by Nucleic Acid-Mediated PAR1b Multimerization.

Authors:  Hiroko Nishikawa; Priscillia Christiany; Takeru Hayashi; Hisashi Iizasa; Hironori Yoshiyama; Masanori Hatakeyama
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

Review 5.  Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease.

Authors:  Dacie R Bridge; D Scott Merrell
Journal:  Gut Microbes       Date:  2013-02-04

6.  Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein-Barr virus.

Authors:  Priya Saju; Naoko Murata-Kamiya; Takeru Hayashi; Yoshie Senda; Lisa Nagase; Saori Noda; Keisuke Matsusaka; Sayaka Funata; Akiko Kunita; Masayuki Urabe; Yasuyuki Seto; Masashi Fukayama; Atsushi Kaneda; Masanori Hatakeyama
Journal:  Nat Microbiol       Date:  2016-03-14       Impact factor: 17.745

7.  Structural insights into Helicobacter pylori oncoprotein CagA interaction with β1 integrin.

Authors:  Burcu Kaplan-Türköz; Luisa F Jiménez-Soto; Cyril Dian; Claudia Ertl; Han Remaut; Arthur Louche; Tommaso Tosi; Rainer Haas; Laurent Terradot
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

8.  A specific A/T polymorphism in Western tyrosine phosphorylation B-motifs regulates Helicobacter pylori CagA epithelial cell interactions.

Authors:  Xue-Song Zhang; Nicole Tegtmeyer; Leah Traube; Shawn Jindal; Guillermo Perez-Perez; Heinrich Sticht; Steffen Backert; Martin J Blaser
Journal:  PLoS Pathog       Date:  2015-02-03       Impact factor: 6.823

9.  Natural variant of the Helicobacter pylori CagA oncoprotein that lost the ability to interact with PAR1.

Authors:  Kana Hashi; Naoko Murata-Kamiya; Christine Varon; Francis Mégraud; Maria Gloria Dominguez-Bello; Masanori Hatakeyama
Journal:  Cancer Sci       Date:  2014-02-12       Impact factor: 6.716

10.  Conformational analysis of isolated domains of Helicobacter pylori CagA.

Authors:  Amanda P Woon; Abolghasem Tohidpour; Hernan Alonso; Yumiko Saijo-Hamano; Terry Kwok; Anna Roujeinikova
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.